Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer [Yahoo! Finance]
Medpace Holdings, Inc. (MEDP)
Last medpace holdings, inc. earnings: 4/28 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.medpace.com
Company Research
Source: Yahoo! Finance
Copenhagen, Denmark, May 19, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces the appointment of Steven Johnson as Chief Development Officer. Steven will join the executive team to lead regulatory and development strategies at Zealand Pharma. His appointment, alongside Chief Medical Officer, David Kendall and recently appointed Chief Scientific Officer, Utpal Singh further strengthens the company's strategy to lead the field in innovation in the management of obesity and other related conditions. Steven brings nearly 30 years of experience driving drug development and regulatory strategy across the pharmaceutical industry. He joins Zealand Pharma from UCB Biopharma, where he most recently served as Senior Vice President and Head of Regulatory Stakeholders, responsible for leading late phase clinical development, global regulatory affairs, biometrics an
Show less
Read more
Impact Snapshot
Event Time:
MEDP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MEDP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MEDP alerts
High impacting Medpace Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
MEDP
News
- Medpace (MEDP): Has the Recent Pullback Opened a Valuation Opportunity for Long-Term Investors? [Yahoo! Finance]Yahoo! Finance
- Assessing Medpace Holdings After a 70% Rally and Recent Pullback in 2025 [Yahoo! Finance]Yahoo! Finance
- Medpace (NASDAQ:MEDP) had its "underweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- How Medpace's Q3 2025 Surge and Buybacks Strategy Could Impact Medpace Holdings (MEDP) Investors [Yahoo! Finance]Yahoo! Finance
- 2 Profitable Stocks to Keep an Eye On and 1 We Find Risky [Yahoo! Finance]Yahoo! Finance
MEDP
Earnings
- 10/22/25 - Beat
MEDP
Sec Filings
- 12/9/25 - Form 4
- 12/4/25 - Form 4
- 12/4/25 - Form 4
- MEDP's page on the SEC website